Infantile hemangioma is a benign tumor originating from blood vessels in the skin, mostly found in the skin of the head and neck, but can also occur in mucous membranes, liver, brain and muscles. They appear at birth or within three to six months after birth and affect the baby’s appearance, and generally grow more rapidly from 2 to 8 months. Depending on the location and size of the hemangioma, it can be classified as high, medium or low risk. The treatment plan differs according to the risk level. (1) High risk: segmental hemangioma >5 cm —- face; segmental hemangioma >5 cm —- lumbosacral and perineal area; non-segmental large hemangioma —- face (thickness up to dermis or subcutaneous, or obviously elevated skin surface); early hemangioma with white hypopigmentation; mid-facial hemangioma; periocular, perinasal and perioral hemangioma. Treatment options for high-risk hemangiomas: Treatment should be started as early as possible, preferably at 4 weeks of life or earlier. First-line treatment is oral propranolol therapy, and systemic glucocorticoid therapy if oral propranolol is contraindicated. (2) Moderate risk: angiomas on both sides of the face, scalp, hands and feet; angiomas in the trunk folds (neck, perineum, axilla); segmental angiomas >5 cm —- trunk and extremities. Treatment plan for moderate risk hemangioma: early treatment should be given with topical β-blockers, local restraint therapy or pulsed dye laser treatment; if the tumor continues to grow or complications such as ulceration occur during treatment, the treatment plan for high risk hemangioma is followed. (3) Low risk: The trunk and extremities are not obvious. Treatment plan for low-risk hemangioma: You can observe first and review monthly within 6 months. If the tumor grows rapidly, follow the treatment plan for moderate-risk hemangioma.